Literature DB >> 31186533

C10ORF12 modulates PRC2 histone methyltransferase activity and H3K27me3 levels.

Yi Shi1, Hong-Lei Ma2, You-Wen Zhuang2,3, Xiao-Xi Wang2, Yi Jiang4,5, H Eric Xu6,7,8.   

Abstract

The polycomb repressive complex 2 (PRC2) catalyzes the methylation of histone H3 on lysine 27 (H3K27) to generate trimethyl-H3K27 (H3K27me3) marks, thereby leading to a repressive chromatin state that inhibits gene expression. C10ORF12 was recently identified as a novel PRC2 interactor. Here, we show that C10ORF12 specifically interacts with PRC2 through its middle region (positions 619-718). C10ORF12 significantly enhances the histone methyltransferase activity of PRC2 in vitro and dramatically increases the total H3K27me3 levels in HeLa cells. C10ORF12 also antagonizes Jarid2, which is an auxiliary factor of the PRC2.2 subcomplex, to promote increased H3K27me3 levels in HeLa cells. Moreover, C10ORF12 alters the substrate preference of PRC2. These results indicate that C10ORF12 functions as a positive regulator of PRC2 and facilitates PRC2-mediated H3K27me3 modification of chromatin. These findings provide new insight into the roles of C10ORF12 in regulating the activity of the PRC2 complex.

Entities:  

Keywords:  C10ORF12; H3K27me3; PRC2; epigenetic regulation; histone methyltransferase; histone modification

Mesh:

Substances:

Year:  2019        PMID: 31186533      PMCID: PMC6889301          DOI: 10.1038/s41401-019-0247-3

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  66 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 2.  Polycomb group protein-mediated repression of transcription.

Authors:  Lluís Morey; Kristian Helin
Journal:  Trends Biochem Sci       Date:  2010-03-24       Impact factor: 13.807

Review 3.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

Review 4.  Targeting epigenetic enzymes for drug discovery.

Authors:  Robert A Copeland; Edward J Olhava; Margaret Porter Scott
Journal:  Curr Opin Chem Biol       Date:  2010-08       Impact factor: 8.822

5.  Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.

Authors:  Michiel Vermeulen; H Christian Eberl; Filomena Matarese; Hendrik Marks; Sergei Denissov; Falk Butter; Kenneth K Lee; Jesper V Olsen; Anthony A Hyman; Henk G Stunnenberg; Matthias Mann
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

Review 6.  Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put.

Authors:  Jeffrey A Simon; Robert E Kingston
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

Review 7.  The Polycomb complex PRC2 and its mark in life.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nature       Date:  2011-01-20       Impact factor: 49.962

Review 8.  Chromatin structure and the inheritance of epigenetic information.

Authors:  Raphaël Margueron; Danny Reinberg
Journal:  Nat Rev Genet       Date:  2010-04       Impact factor: 53.242

9.  Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome.

Authors:  Robert K McGinty; Ryan C Henrici; Song Tan
Journal:  Nature       Date:  2014-10-30       Impact factor: 49.962

10.  Interdependence of PRC1 and PRC2 for recruitment to Polycomb Response Elements.

Authors:  Tatyana G Kahn; Eshagh Dorafshan; Dorothea Schultheis; Aman Zare; Per Stenberg; Ingolf Reim; Vincenzo Pirrotta; Yuri B Schwartz
Journal:  Nucleic Acids Res       Date:  2016-08-23       Impact factor: 16.971

View more
  3 in total

Review 1.  Polycomb Gene Silencing Mechanisms: PRC2 Chromatin Targeting, H3K27me3 'Readout', and Phase Separation-Based Compaction.

Authors:  Yiran Guo; Shuai Zhao; Gang Greg Wang
Journal:  Trends Genet       Date:  2021-01-22       Impact factor: 11.639

Review 2.  Altered pathways and targeted therapy in double hit lymphoma.

Authors:  Yuxin Zhuang; Jinxin Che; Meijuan Wu; Yu Guo; Yongjin Xu; Xiaowu Dong; Haiyan Yang
Journal:  J Hematol Oncol       Date:  2022-03-18       Impact factor: 17.388

3.  PALI1 facilitates DNA and nucleosome binding by PRC2 and triggers an allosteric activation of catalysis.

Authors:  Qi Zhang; Samuel C Agius; Sarena F Flanigan; Michael Uckelmann; Vitalina Levina; Brady M Owen; Chen Davidovich
Journal:  Nat Commun       Date:  2021-07-28       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.